The Trump administration agreed to drop a controversial pilot that would have allowed drugmakers to give post-sales rebates on some drugs instead of upfront discounts.Dive Brief:The HHS is scrapping a rebate pilot in the 340B drug discount program, ending the controversial trial before it got off the ground. The pilot would have allowed pharmaceutical manufacturers […]
